Abstract
An arteriovenous fistula (AVF) remains the preferred access for providing maintenance hemodialysis therapy. An AVF is commonly created in the forearm or the upper arm using native vessels, and it generally matures over a 2–3-month period. A dysfunctional AVF due to primary maturation failure is a common problem encountered in clinical practice. The skills needed to perform a thorough and accurate physical examination of an AVF can be easily learned by everyone involved in the care of a dialysis patient. A thrill is produced because of the turbulence generated by the high-pressure arterial blood flowing across the anastomosis into a low-pressure thin-walled vein. A faint thrill is an indicator of pathology in the inflow segment of the AVF, and the algorithm to identify the abnormality within the dialysis access circuit is discussed here.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
A well-functioning dialysis vascular access is crucial for providing adequate hemodialysis treatment. Arteriovenous fistula (AVF) remains the preferred vascular access among all the other available options, which include arteriovenous graft (AVG), central venous catheters (CVC), or a hybrid access (combination of AVF-AVG or AVG-CVC). Low incidence of infections and thrombosis and lower maintenance costs are the primary reasons to prefer AVF over other vascular access types [1–4]. Once the initial challenge to attain a mature and functional AVF is overcome, maintaining its patency is relatively easy as compared to AVG.
Arteriovenous fistula is commonly created in the upper extremity either in the forearm or in the upper arm using native vessels. AVF in the lower extremity is uncommon but can be created in select group of patients. The common sites for AVF creation are listed in Table 15.1 [5, 6].
The clinical practice guidelines from the Kidney Dialysis Outcomes and Quality Initiatives recommend establishing a monitoring program for early identification of dysfunctional AVF [7]. Monitoring is defined as performing a detailed physical examination of the vascular access and remains a key component in the evaluation of an AVF. Physical examination is a simple, cost-effective, reproducible, and a validated tool that can be effectively utilized for the assessment of an AVF. Physical examination can be easily performed on every dialysis patient and is mandated in the USA as per 2008 requirements established by the Centers for Medicare and Medicaid Services [6, 8]. An experienced dialysis nurse can diagnose a mature AVF with 80 % accuracy by physical examination alone, a fact validated with ultrasound evaluation of 69 patients with a newly placed AVF [9].
Several studies have confirmed the value of this bedside tool in accurately diagnosing both the inflow and outflow stenoses in an AVF with 85–90 % sensitivity and 75–80 % specificity [10–12]. The physical examination performed by a nephrology fellow after 4 weeks of intense training has been shown to be 100 % sensitive and 78 % specific for inflow stenosis and 76 % sensitive and 68 % specific for outflow stenosis [13].
15.1 Components of an Arteriovenous Fistula
An AVF is a continuous circuit and not merely a surgical anastomosis between an artery and vein. The circuit starts at the heart and ends at the heart, and examining the entire circuit is absolutely essential to evaluate an AVF. Besides the right and left side of the heart, the other components of AVF are the entire arterial and venous system of the extremity and the central veins. An AVF can be examined in three segments (Fig. 15.1): (a) the inflow segment includes the feeding artery, the arteriovenous anastomosis, and the juxta-anastomotic region; (b) the main body includes the cannulation segment that is used to access an AVF during hemodialysis; and (c) the outflow segment includes the veins (including the central veins) proximal to the main body that return the blood to the heart.
15.2 Physical Examination of an Arteriovenous Fistula
15.2.1 Normal Findings
A normal AVF is soft and compressible. A distinct pulse with a continuous thrill is present at the inflow segment and along the majority of the body of the AVF. The thrill tends to dissipate as the palpating finger is moved proximally along the outflow segment. On auscultation the bruit is a low-pitch sound heard during the entire cardiac cycle. The bruit is loudest at the arterial anastomosis and fades along the outflow segment.
15.2.2 Augmentation Test
A feeble pulse at the inflow segment accompanied by a faint thrill is an abnormal finding that needs further evaluation with an “augmentation” test. The test is performed by manually occluding the outflow in the main body of the AVF. The pulse in the inflow segment gets strong and forceful, also called “water hammer pulse” in a normal well-functioning AVF. In a dysfunctional AVF, the manual occlusion of the outflow fails to augment the inflow segment suggestive of inflow pathology. The augmentation test is schematically shown in Fig. 15.2. The thrill and bruit accompanying a feeble pulse are proportionately faint. Additionally, the bruit may be heard only during the systolic phase of the cardiac cycle [14].
15.3 Etiology of a Faint Thrill
A faint thrill on physical examination with failed augmentation test localizes the pathology to the inflow segment. The thrill is produced because of the turbulence created by the blood flowing from an artery with high pressure across the arteriovenous anastomosis into a thin-walled vein with low pressure. The high pressure in the artery is maintained by a well-functioning cardiac pump. Any pathology that can compromise any of these components will lead to a physical examination finding of weak pulse and faint thrill. The common etiological factors are listed in Table 15.2.
Hemodynamic status and uremic milieu are key components to maintaining AVF patency. A generally accepted clinical practice dogma is for patients to have a minimum systolic blood pressure of 100 mmHg for AVF to mature. Once an AVF matures, the incidence of AVF dysfunction, especially thrombosis, is frequent with hypotensive episodes during dialysis, highlighting the importance of hemodynamic factors [15].
In a newly created AVF, small vessel size and poor surgical technique often lead to early development of stenosis at the anastomosis site resulting in faint thrill on clinical examination [16]. “Swing site” is the segment of the vessel that is mobilized to create the anastomosis, which for radiocephalic and brachiocephalic fistulas is the juxta-anastomotic region. “Swing site” segment stenosis accounts for 65–70 % of early AVF maturation failures [17].
A fully matured AVF generally needs much less attention compared to AVG. Nevertheless, stenosis remains a major hurdle for long-term patency of AVF. Stenosis is frequently seen at the juxta-anastomotic region secondary to neointimal hyperplasia and smooth muscle cell proliferation. As yet, the exact pathophysiology behind neointimal hyperplasia remains unclear [18, 19].
15.4 Practical Approach for Timely Intervention
Inflow segment pathology can be identified with frequent physical examination of an AVF. A newly created AVF generally matures to support hemodialysis treatment in 8–12 weeks after the surgery. An AVF with blood flow of 500–600 ml/min and luminal diameter of 6 mm is considered to be mature enough to support regular dialysis treatments. KDOQI clinical practice guidelines recommend everyone involved in the care of dialysis patients to be proficient in the physical examination of an AVF. A simple algorithm based on whether an AVF is new or established can assist with identifying the problem sooner for timely intervention.
15.4.1 New AVF
A successful AVF undergoes changes that are predictable with incremental increase in blood flow and vessel size over a 4–6-week period after the surgery. All newly created AVFs need to be examined at least by 6 weeks to identify a failing maturity process. Further management and intervention in a newly created AVF with faint thrill is outlined in Fig. 15.3. The examination of a newly created AVF should be performed by a skilled personnel and include an “augmentation test.” If the augmentation test is negative, further testing involving either an ultrasonography or an angiography can help identify the problem for timely intervention. Ultrasound evaluation is a noninvasive test but can help only with confirming the physical examination findings. Moreover, the test adds to the overall cost of care. Angiography is a definitive test that can help identify the stenosis and correct the pathology by simultaneously performing an angioplasty. Inflow stenosis is a very commonly diagnosed problem, and early intervention has helped salvage a great majority of early failed AVF. In a study of 100 cases with early AVF failure, 78 % had significant stenosis identified as an etiology for poor maturation. Percutaneous angioplasty was successful in 98 % of these cases, and 92 % of AVFs were successfully salvaged following intervention [20].
If the augmentation test is positive at 6 weeks, an AVF can be monitored regularly at 1–2-week intervals for a maximum of 12 weeks. If at the end of 12 weeks, an AVF remains immature, then further investigation with fistulography should be considered. Waiting longer than 12 weeks, hoping for an AVF to mature, is generally not in the patient’s best interest. Active and aggressive intervention can help salvage these immature fistulas and shorten the duration of alternate vascular access, which is invariably a tunneled central venous catheter. If a fistulogram fails to identify any correctable pathology to assist with AVF maturation process, alternate plans to create another permanent vascular access should be made immediately, and the patient needs to be referred back to the surgeon.
15.4.2 Established AVF
Hemodialysis process is complex and involves constant monitoring of the patient as well as the hemodialysis machine. A complete and thorough physical examination of an established AVF should be performed before each dialysis treatment by skilled dialysis personnel. During the treatment process, various settings on the hemodialysis machines, such as speed of the blood pump, and arterial and venous pressure monitoring are routinely performed by the dialysis staff. The quality of the dialysis treatment is judged by measuring the solute clearance from blood tests performed on a monthly basis. Figure 15.4 outlines the clinical approach for evaluating an established AVF with faint thrill. The algorithm incorporates the physical examination findings and other hemodialysis machine parameters and provides a practical approach to identify a failing AVF. The average blood flow prescribed for hemodialysis treatment in the USA is around 350–400 ml/min. The dialysis arterial pressure recorded with 350–400 ml/min blood flow from a well-functioning AVF is generally less than negative 200 mmHg. Inflow segment stenosis is less than likely, if the prescribed blood flow is not achieved or the arterial pressure is more than negative 200, along with faint thrill at inflow.
A significant inflow segment stenosis is unable to support the high blood flows necessary to provide adequate dialysis treatment. The inability to achieve the prescribed blood flow during treatment leads to high arterial pressures on hemodialysis machine and frequent tripping of arterial alarm limits. The end result is high recirculation rate with inadequate solute clearances on monthly blood tests. Timely identification of these abnormal findings can assist with early intervention of the underlying stenosis. Vascular stenosis is a progressive process that will ultimately culminate in complete occlusion and thrombosis and eventual loss of flow. The next step in the management is confirming the physical examination findings with either an ultrasonography or an invasive angiography. Fistulogram remains the gold standard test to confirm stenosis. Once the diagnosis is confirmed, simultaneous angioplasty can help maintain the access patency.
15.5 Summary
Inflow segment stenosis in both new and established AVF can be diagnosed with a well-performed physical examination by skilled dialysis personnel. Regular monitoring of an AVF can help with early diagnosis for timely intervention to maintain access patency. A simple algorithm utilizing clues obtained from physical examination, blood flows and arterial pressures from dialysis machines, and monthly laboratory test results can effectively help diagnose inflow segment pathology.
References
Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002;61(1):305–16.
Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002;40(3):611–22.
Vascular Access Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48 Suppl 1:S248–73.
Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44(5):779–91.
Vachharajani TJ. Atlas helps renal staff identify access problems. Nephrol News Issues. 2011;25(2):24.
Fistula First Breakthrough Initiative www.fistulafirst.org; 2013. Accessed on 26 Oct 2013.
Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48 Suppl 1:S176–247.
Abreo K, Allon M, Asif A, Atray N, Besarab A, Dember LM, Dixon BS, DeVita M, Kaufman J, Murray BM, et al. Which direction is right for vascular access surveillance? A debate. Nephrol News Issues. 2010;24(7):30.
Robbin ML, Chamberlain NE, Lockhart ME, Gallichio MH, Young CJ, Deierhoi MH, Allon M. Hemodialysis arteriovenous fistula maturity: US evaluation. Radiology. 2002;225(1):59–64.
Campos RP, Chula DC, Perreto S, Riella MC, do Nascimento MM. Accuracy of physical examination and intra-access pressure in the detection of stenosis in hemodialysis arteriovenous fistula. Semin Dial. 2008;21(3):269–73.
Asif A, Leon C, Orozco-Vargas LC, Krishnamurthy G, Choi KL, Mercado C, Merrill D, Thomas I, Salman L, Artikov S, et al. Accuracy of physical examination in the detection of arteriovenous fistula stenosis. Clin J Am Soc Nephrol. 2007;2(6):1191–4.
Coentrao L, Faria B, Pestana M. Physical examination of dysfunctional arteriovenous fistulae by non-interventionalists: a skill worth teaching. Nephrol Dial Transplant. 2012;27(5):1993–6.
Leon C, Asif A. Physical examination of arteriovenous fistulae by a renal fellow: does it compare favorably to an experienced interventionalist? Semin Dial. 2008;21(6):557–60.
Beathard GA. A practitioner’s resource guide to physical examination of dialysis vascular access http://fistulafirst.org/Professionals/Literature.aspx; 2013. Accessed on 26 Oct 2013.
Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, Chertow GM. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011;22(8):1526–33.
Saran R, Elder SJ, Goodkin DA, Akiba T, Ethier J, Rayner HC, Saito A, Young EW, Gillespie BW, Merion RM, et al. Enhanced training in vascular access creation predicts arteriovenous fistula placement and patency in hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study. Ann Surg. 2008;247(5):885–91.
Badero OJ, Salifu MO, Wasse H, Work J. Frequency of swing-segment stenosis in referred dialysis patients with angiographically documented lesions. Am J Kidney Dis. 2008;51(1):93–8.
Roy-Chaudhury P, Arend L, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, Samaha A, Munda R. Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis. 2007;50(5):782–90.
Lee T, Roy-Chaudhury P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis. 2009;16(5):329–38.
Asif A, Roy-Chaudhury P, Beathard GA. Early arteriovenous fistula failure: a logical proposal for when and how to intervene. Clin J Am Soc Nephrol. 2006;1(2):332–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Vachharajani, T.J. (2014). Approach to an Arteriovenous Access with a Faint Thrill. In: Yevzlin, A., Asif, A., Salman, L. (eds) Interventional Nephrology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8803-3_15
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8803-3_15
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8802-6
Online ISBN: 978-1-4614-8803-3
eBook Packages: MedicineMedicine (R0)